Seefeldt M - Search Results

1

Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model.

Wemlinger SM, Parker Harp CR, Yu B, Hardy IR, Seefeldt M, Matsuda J, Mingueneau M, Spilker KA, Cameron TO, Larrick JW, Getahun A, Cambier JC. Wemlinger SM, et al. Among authors: seefeldt m. J Immunol. 2022 Apr 1;208(7):1566-1584. doi: 10.4049/jimmunol.2101056. Epub 2022 Mar 23. J Immunol. 2022. PMID: 35321883 Free PMC article.

2

Anti-CD79 antibody induces B cell anergy that protects against autoimmunity.

Hardy IR, Anceriz N, Rousseau F, Seefeldt MB, Hatterer E, Irla M, Buatois V, Chatel LE, Getahun A, Fletcher A, Cons L, Pontini G, Hertzberg NA, Magistrelli G, Malinge P, Smith MJ, Reith W, Kosco-Vilbois MH, Ferlin WG, Cambier JC. Hardy IR, et al. Among authors: seefeldt mb. J Immunol. 2014 Feb 15;192(4):1641-50. doi: 10.4049/jimmunol.1302672. Epub 2014 Jan 17. J Immunol. 2014. PMID: 24442438 Free PMC article.

3

Sheep recombinant IGF-1 promotes organ-specific growth in fetal sheep.

Stremming J, White A, Donthi A, Batt DG, Hetrick B, Chang EI, Wesolowski SR, Seefeldt MB, McCurdy CE, Rozance PJ, Brown LD. Stremming J, et al. Among authors: seefeldt mb. Front Physiol. 2022 Aug 25;13:954948. doi: 10.3389/fphys.2022.954948. eCollection 2022. Front Physiol. 2022. PMID: 36091374 Free PMC article.

4

High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.

Seefeldt MB, Kim YS, Tolley KP, Seely J, Carpenter JF, Randolph TW. Seefeldt MB, et al. Protein Sci. 2005 Sep;14(9):2258-66. doi: 10.1110/ps.051490205. Epub 2005 Aug 4. Protein Sci. 2005. PMID: 16081653 Free PMC article.

5

High-pressure refolding of bikunin: efficacy and thermodynamics.

Seefeldt MB, Ouyang J, Froland WA, Carpenter JF, Randolph TW. Seefeldt MB, et al. Protein Sci. 2004 Oct;13(10):2639-50. doi: 10.1110/ps.04891204. Protein Sci. 2004. PMID: 15388859 Free PMC article.

6

High hydrostatic pressure as a tool to study protein aggregation and amyloidosis.

Randolph TW, Seefeldt M, Carpenter JF. Randolph TW, et al. Among authors: seefeldt m. Biochim Biophys Acta. 2002 Mar 25;1595(1-2):224-34. doi: 10.1016/s0167-4838(01)00346-6. Biochim Biophys Acta. 2002. PMID: 11983398 Review.

7

Specific volume and adiabatic compressibility measurements of native and aggregated recombinant human interleukin-1 receptor antagonist: density differences enable pressure-modulated refolding.

Seefeldt MB, Crouch C, Kendrick B, Randolph TW. Seefeldt MB, et al. Biotechnol Bioeng. 2007 Oct 1;98(2):476-85. doi: 10.1002/bit.21398. Biotechnol Bioeng. 2007. PMID: 17335058

8

High-pressure studies on protein aggregates and amyloid fibrils.

Kim YS, Randolph TW, Seefeldt MB, Carpenter JF. Kim YS, et al. Methods Enzymol. 2006;413:237-53. doi: 10.1016/S0076-6879(06)13013-X. Methods Enzymol. 2006. PMID: 17046400

9

Application of high hydrostatic pressure to dissociate aggregates and refold proteins.

Seefeldt MB, Rosendahl MS, Cleland JL, Hesterberg LK. Seefeldt MB, et al. Curr Pharm Biotechnol. 2009 Jun;10(4):447-55. doi: 10.2174/138920109788488914. Curr Pharm Biotechnol. 2009. PMID: 19519422 Review.

10

Confronting high-throughput protein refolding using high pressure and solution screens.

Qoronfleh MW, Hesterberg LK, Seefeldt MB. Qoronfleh MW, et al. Among authors: seefeldt mb. Protein Expr Purif. 2007 Oct;55(2):209-24. doi: 10.1016/j.pep.2007.05.014. Epub 2007 Jun 2. Protein Expr Purif. 2007. PMID: 17681810 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page